UNSPSC 51422106: Fluocortolone

This classification denotes a therapeutic glucocorticoid with the molecular formula C22H29FO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 65VXC1MH0J, chemically known as 6-alpha-fluoro-16-alpha-methylpregna-1,4-diene-11-beta,21-diol-3,20-dione but generally known as fluocortolone, which bears US NIH Compound Identifier 9053. European Medicines Agency schedules Fluocortolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07717MIG.

UNSPSC 51422106 Fluocortolone is a Commodity code that describes pharmaceutical products, but the recent state and local opportunities tagged under it do not reflect purchases of fluocortolone itself. Instead, the posted solicitations show procurement of naloxone and drug deactivation systems (Seminole County, Florida) and exploratory market research into direct-to-manufacturer prescription fulfillment programs (Texas Health and Human Services Commission). The code shows minimal relevant recent activity; the mismatch between the nominal commodity scope and actual solicitation content suggests either miscoding at the source or that fluocortolone procurement does not currently generate visible state and local bidding opportunities.

Seminole County posted an Invitation for Bid (IFB 60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a response deadline of July 26, 2023. Texas HHS issued a Request for Information (RFI HHS0017013) on April 3, 2026, to gather vendor capabilities on direct-to-manufacturer prescription programs for state pharmacy benefit management, posted and due April 3, 2026. Neither opportunity directly aligns with fluocortolone procurement. The code warrants monitoring for future activity, but current visibility into active state and local fluocortolone solicitations is absent.